Development of a trivalent adjuvanted sub-unit vaccine candidate for Covid-19: From antigen expression to Ind-enabling Cmc and preclinical studies

Authors

• Leda R. Castilho, UFRJ, BrazilFollow
• Renata G. F. Alvim, COPPE, Federal University of Rio de Janeiro (UFRJ), Brazil
• Tulio M. Lima, COPPE, Federal University of Rio de Janeiro (UFRJ), Brazil
• Luiza Abdo, National Cancer Institute (INCA), Brazil
• Karina Hadju, National Cancer Institute (INCA), Brazil
• Daniel P. B. Abreu, COPPE, Federal University of Rio de Janeiro (UFRJ), Brazil
• Patricia R. C . França, COPPE and ICB, Federal University of Rio de Janeiro (UFRJ), Brazil
• Gabriane Porcino, COPPE, Federal University of Rio de Janeiro (UFRJ), Brazil
• Fernanda Bittencourt, COPPE, Federal University of Rio de Janeiro (UFRJ), Brazil
• Ana L. Habigzang, COPPE, Federal University of Rio de Janeiro (UFRJ), Brazil
• Federico F. l Marsili, COPPE and IQ, Federal University of Rio de Janeiro (UFRJ), Brazi
• Hiam Arruda, IBqM, Federal University of Rio de Janeiro (UFRJ), Brazil
• Guilherme A. Oliveira, IBqM, Federal University of Rio de Janeiro (UFRJ), Brazil
• Renato S. Carvalho, FF, Federal University of Rio de Janeiro (UFRJ), Brazil
• Martin H. Bonamino, National Cancer Institute (INCA), Brazil

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Leda R. Castilho, Renata G. F. Alvim, Tulio M. Lima, Luiza Abdo, Karina Hadju, Daniel P. B. Abreu, Patricia R. C . França, Gabriane Porcino, Fernanda Bittencourt, Ana L. Habigzang, Federico F. l Marsili, Hiam Arruda, Guilherme A. Oliveira, Renato S. Carvalho, and Martin H. Bonamino, "Development of a trivalent adjuvanted sub-unit vaccine candidate for Covid-19: From antigen expression to Ind-enabling Cmc and preclinical studies" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/24